We are live on ! Find out more
BIO.B icon

Bio-Rad Laboratories Class B
BIO.B

6 hedge funds and large institutions have $7.03M invested in Bio-Rad Laboratories Class B in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more funds holding

Funds holding: 5 → 6 (+1)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.09% less ownership

Funds ownership: 0.7% → 0.61% (-0.09%)

13% less capital invested

Capital invested by funds: $8.11M → $7.03M (-$1.08M)

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$211K
2
UBS Group
UBS Group
Switzerland
+$38.6K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$1.36M

BIO.B Hedge Fund Activity: Q3 2017 in Review

6 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q3 2017, worth a combined $7.03M — down 13% from $8.11M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new BIO.B positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $211K. The largest seller was Bank of America, cutting an estimated $1.36M.

  • 6 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q3 2017, up from 5 in Q2 2017.
  • Funds reported $7.03M of Bio-Rad Laboratories Class B stock for Q3 2017, down 13% quarter-over-quarter.
  • 1 fund opened new Bio-Rad Laboratories Class B positions in Q3 2017 and 0 closed out, a net change of +1 holder.
  • The largest Bio-Rad Laboratories Class B buyer in Q3 2017 was Susquehanna International Group, an estimated $211K added.
  • The largest Bio-Rad Laboratories Class B seller in Q3 2017 was Bank of America, an estimated $1.36M sold.

Based on aggregated 13F filings for Q3 2017.